0
Manufacturing Facilities To Explore
0
Product Types Covered
Tracker Highlights
left
right
comprehensive information

Competitive Assessment

This tracker provides an in-depth overview of the upcoming competition in the East Asian Bioprocessing market.

Through this tracker IMAPAC aims to assist organizations to keep track of their competitors, identify any opportunities for collaboration or investments for development or manufacturing of large molecules in the East Asia region, aiding in key strategic decisions for biopharma business industry.

Explore More, Request A Demoright

Product Types Covered

Antibody Therapeutics, Protein Therapeutics, Vaccines, Cell Therapy, Gene Therapy, Immunotherapeutics, Blood & Plasma

Explore More, Request A Demoright

Key Parameters

Company name, in-house capabilities, product types and sub-products,  bioprocessing capabilities & processes, the scale of operation or phases of development, plant capacity & batch size, facility size, current & completed projects of CMOs, facility name, location, establishment year, facility size & capacity, process technology, bioreactor type, technology/service providers, ongoing projects/pipeline, annual production, batch size, bioprocessing equipment, bioreactors, expression system, regulatory approval, investments, future expansion plans, partnerships & collaborations and other parameters.

Explore More, Request A Demoright

Key Companies Covered

Samsung Biologics, Lonza, Beigene, Patheon, ExoCoBio, Bioworkshops, Biocin

Explore More, Request A Demoright

Countries Coverage

China, Japan, South Korea, Hong Kong and Taiwan among many more

Explore More, Request A Demoright
bag